switching from insulin to glp-1 between GLP‐1 receptor agonists in clinical practice: Expert consensus and practical guidance Switching GLP1 Medications Is Common

Nasseri and his team customize each infusion based on your health status and goals, ensuring a safe, effective, and personalized wellness experience

In the multiple-dose part of the trial, participants who received a 140 mg dose of AMG 133 lost an average of 7.4% of their body weight by Day 78 after three doses

AI-driven treatment selection : using machine learning models trained on clinical, genomic, and imaging data to guide drug choice and dosage

It was a combination of public health measures and smart, safe pharmacotherapy

This review aims to synthesize the available literature on the use of GLP-1 RAs in HS and psoriasis, evaluate their emerging clinical relevance, and identify areas where more research is needed